101 related articles for article (PubMed ID: 22642991)
1. [Mutations in genes involved in splicing in human malignancies].
Damm F; Nguyen-Khac F; Kosmider O; Fontenay M; Bernard OA
Med Sci (Paris); 2012 May; 28(5):449-53. PubMed ID: 22642991
[No Abstract] [Full Text] [Related]
2. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
3. A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages.
Gentien D; Kosmider O; Nguyen-Khac F; Albaud B; Rapinat A; Dumont AG; Damm F; Popova T; Marais R; Fontenay M; Roman-Roman S; Bernard OA; Stern MH
Leukemia; 2014 Jun; 28(6):1355-7. PubMed ID: 24434863
[No Abstract] [Full Text] [Related]
4. Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies.
Damm F; Nguyen-Khac F; Fontenay M; Bernard OA
Leukemia; 2012 Sep; 26(9):2027-31. PubMed ID: 22484420
[TBL] [Abstract][Full Text] [Related]
5. Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia.
Ramsay AJ; Rodríguez D; Villamor N; Kwarciak A; Tejedor JR; Valcárcel J; López-Guillermo A; Martínez-Trillos A; Puente XS; Campo E; López-Otín C; Quesada V
Leukemia; 2013 Jul; 27(7):1600-3. PubMed ID: 23187293
[No Abstract] [Full Text] [Related]
6. [p53 and hematologic malignancies].
Preudhomme C; Fenaux P
Pathol Biol (Paris); 1997 Dec; 45(10):898-908. PubMed ID: 9769955
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the WT1 gene in childhood nonlymphoid hematological malignancies.
Miyagawa K; Hayashi Y; Fukuda T; Mitani K; Hirai H; Kamiya K
Genes Chromosomes Cancer; 1999 Jun; 25(2):176-83. PubMed ID: 10338002
[TBL] [Abstract][Full Text] [Related]
8. Insights into the connection between cancer and alternative splicing.
Kim E; Goren A; Ast G
Trends Genet; 2008 Jan; 24(1):7-10. PubMed ID: 18054115
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein (RBFOX1) inherited polymorphism rs8051518 is not associated with splice factor mutations in myelodysplastic syndromes and myeloproliferative neoplasms.
Faisal M; Büsche G; Schlue J; Kreipe H; Lehmann U; Bartels S
Ann Hematol; 2019 May; 98(5):1297-1299. PubMed ID: 30159600
[No Abstract] [Full Text] [Related]
10. Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia.
Pekova S; Cmejla R; Smolej L; Kozak T; Spacek M; Prucha M
Leuk Res; 2008 Mar; 32(3):395-400. PubMed ID: 17688945
[TBL] [Abstract][Full Text] [Related]
11. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia.
Mabuchi H; Fujii H; Calin G; Alder H; Negrini M; Rassenti L; Kipps TJ; Bullrich F; Croce CM
Cancer Res; 2001 Apr; 61(7):2870-7. PubMed ID: 11306461
[TBL] [Abstract][Full Text] [Related]
13. [Review of relationship between tumor necrosis factor genetic polymorphism and hematological malignancies].
Zhao HY; Chen YX
Ai Zheng; 2003 Feb; 22(2):216-20. PubMed ID: 12600304
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
Kiss TL; Chang H; Daly A; Messner HA; Jamal N; Spaner D; Rubin S; Lipton JH
Bone Marrow Transplant; 2004 Apr; 33(8):855-8. PubMed ID: 14990983
[TBL] [Abstract][Full Text] [Related]
15. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
Siew-Gek Lee A; Rudduck-Sivaswaren C; Khun-Hong Lie D; Li-Ming Chua C; Tien SL; Morsberger L; Griffin CA
Cancer Genet Cytogenet; 2004 Sep; 153(2):151-7. PubMed ID: 15350305
[TBL] [Abstract][Full Text] [Related]
16. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
[TBL] [Abstract][Full Text] [Related]
17. Application of allele-specific quantitative PCR using genomic DNA to monitor minimal residual disease based on mutant gene levels following allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: comparison of mutant levels with autologous DNA percentage by short tandem repeat-PCR.
Taira C; Matsuda K; Saito S; Sakashita K; Sugano M; Okumura N; Honda T
Clin Chim Acta; 2012 Feb; 413(3-4):516-9. PubMed ID: 22138486
[TBL] [Abstract][Full Text] [Related]
18. Mutations of RNA splicing factors in hematological malignancies.
Shukla GC; Singh J
Cancer Lett; 2017 Nov; 409():1-8. PubMed ID: 28888996
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
Chen Z; Sandberg AA
Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
[TBL] [Abstract][Full Text] [Related]
20. [A progress toward research on alternative splicing of genes in tumor cells].
Zhou ZR; Sun KL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):177-80. PubMed ID: 16604490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
